Travere Therapeutics, Inc. (TVTX) KPIs and segments
Close on Nov 17, 2026Market cap $4.82BP/E –Yield –
KPIs & segments
Operating metrics and segments that drive Travere Therapeutics's business
Travere Therapeutics's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.
The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.
| Add to chart | Metric | Q2 2027 | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net product sales($M) | 161 | 124 | 127 | 113 | 94.8 | 75.9 | 73.5 | 61.0 | 52.2 | 40.0 | 39.9 | 33.9 | |
FILSPARI($M) | 141 | 105 | 103 | 90.9 | 71.9 | 55.9 | 49.6 | 35.6 | 27.1 | 19.8 | 14.7 | 8.04 | |
Tiopronin products($M) | 20.3 | 19.3 | 23.3 | 22.3 | 23.0 | 20.0 | 23.9 | 25.4 | 25.1 | 20.2 | 25.2 | 25.9 | |
License and collaboration revenue($M)1 | 8.23 | 2.71 | 3.08 | 51.7 | 19.6 | 5.87 | 1.24 | 1.90 | 1.94 | 1.39 | 5.14 | 3.16 | |
Non-US($M) | 42.4 | 0 | |||||||||||
Earlier reporting (last reported 2023)2 | |||||||||||||
Net product sales($M) | 159 | 123 | 125 | 112 | 93.3 | 74.6 | 71.2 | 59.4 | 50.2 | 38.5 | 35.4 | 32.6 | |
License and collaboration revenue($M) | 8.23 | 2.71 | 2.26 | 51.4 | 19.6 | 2.45 | 1.08 | 1.90 | 1.81 | 1.39 | 5.14 | 3.16 | |
3 metrics have no data in the last 12 quarters — .
Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).
Methodology and excluded metrics
- Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).
Data updated 2026-08-04.
See a number that looks wrong?